It is however interesting to note that 3′UTR polymorphisms of coagulation factor IX are more frequent than those identified in FVIII and occur in 1.4% of severe and 1.1% mild-moderate HB patients [34]. This evidence concerns the gene F9 and hemoglobin measurement.